RT @drdavidliew: Can fatigue in RA vary by bDMARD used? IL-6 inhibitor treatment associated with attaining a low fatigue
Tweet Content
Can fatigue in RA vary by bDMARD used? IL-6 inhibitor treatment associated with attaining a low fatigue state (RR 1.20 vs csDMARDs).
Given IL-6 secretion with HPA axis activation leads to fatigue/poor sleep, maybe something in this?
RABBIT database OP0020 #EULAR2020 @RheumNow https://t.co/wzFcqdUMMV
Show on Archive Page
On
Display in Search Results
On